Researchers from Google and Beth Israel Deaconess Medical Center published a study on the diagnostic AI chatbot AMIE in the main journal of The Lancet, marking the first time Google research has appeared there, according to the source material. In the study, 98 patients used AMIE before emergency department visits in a real clinical setting, while physicians monitored the interactions in real time and the conversations continued without interruption. Clinicians said AI-generated summaries helped them prepare for patient visits in 75% of scenarios. In more than half of the cases, AMIE’s output changed the physicians’ diagnostic thinking. The study also found that the chatbot’s differential diagnoses matched physicians’ final diagnoses 90% of the time. The reported findings suggest AI may help improve doctor-patient relationships and ease pressure on medical staff.
Google and researchers at Beth Israel Deaconess Medical Center, or BIDMC, have published a study on the diagnostic AI chatbot AMIE in the main journal of The Lancet, according to Techub News.
Trial run in a real emergency care setting
The study was conducted in a real clinical environment. A total of 98 patients used Google’s diagnostic AI chatbot AMIE before their emergency department visits, while physicians monitored the process in real time. All conversations proceeded without interruption.
What clinicians reported
Clinicians said that in 75% of scenarios, AI-generated summaries helped them prepare in advance for patient intake. In more than half of the cases, the AI output changed their diagnostic approach.
The study also found that AMIE’s differential diagnoses matched physicians’ final confirmed diagnoses with 90% agreement.
As cited by QbitAI in the source material, the research suggests AI has the potential to improve doctor-patient relationships and reduce work pressure on healthcare staff.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
